| Case | Controls | Crude OR | Adjusted OR* |
---|
N | % | N | % | OR | 95% CI | OR | 95% CI |
---|
Sensitivity analysis |
Nonusers | 15,294 | 71.0 | 67,570 | 78.5 | 1 | – | 1 | – |
Users | 6234 | 29.0 | 18,542 | 21.5 | 1.51** | 1.46–1.56 | 1.10** | 1.06–1.14 |
- Cases that received laboratory tests specific for AA/AD within 28 days prior to the initial diagnosis of AA/AD and their matched controls were included
- *Adjusted for covariates presented in Table 1 (sex, age, underlying disease, Charlson comorbidity index, medication use, history of procedure/surgery)
- **p < 0.05